This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Pharmacologic Characteristics of Ideal Antidepressants in the 21st Century

C. Lindsay DeVane, PharmD

Published: September 30, 2000

Article Abstract

The availability of drugs for use as antidepressants has expanded greatly in the past 2 decades. Notonly has the number of drugs increased but so has the diversity in associated pharmacologic effects.Drug development for central nervous system agents is proceeding at an accelerated pace. The comingdecades hold the promise for the introduction of newer antidepressants that have novel mechanismsof action, improved adverse event profiles, and expanded indications. Unfortunately, the ideal antidepressantis yet to be formulated. Pharmacologic characteristics for desirable improvements are discussedrelative to the currently available drugs.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...